Codexis (CDXS) EBT Growth (1y) (2011 - 2026)
Codexis (CDXS) EBT Growth (1y) (2011 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBT Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
- |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
-88.68% |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
13.34% |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
-51.60% |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
-313.33% |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
-79.57% |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
-230.18% |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
71.54% |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
- |
| 10 |
Codexis |
236.00 Mn |
170.86 Mn |
13.18 Mn |
58.08% |
| Date | Value |
|---|
| Mar 31, 2026 |
58.08% |
| Dec 31, 2025 |
192.73% |
| Sep 30, 2025 |
4.96% |
| Jun 30, 2025 |
41.69% |
| Mar 31, 2025 |
-79.88% |
| Dec 31, 2024 |
-44.94% |
| Sep 30, 2024 |
40.89% |
| Jun 30, 2024 |
-97.54% |
| Mar 31, 2024 |
49.14% |
| Dec 31, 2023 |
42.53% |
| Sep 30, 2023 |
-249.55% |
| Jun 30, 2023 |
-354.74% |
| Mar 31, 2023 |
-170.77% |
| Dec 31, 2022 |
-23.03% |
| Sep 30, 2022 |
-524.13% |
| Jun 30, 2022 |
40.52% |
| Mar 31, 2022 |
7.93% |
| Dec 31, 2021 |
-158.74% |
| Sep 30, 2021 |
138.75% |
| Jun 30, 2021 |
29.48% |
